Plus, a federal appeals court denies the Trump administration’s bid to avoid fully funding SNAP benefits for November. And Novo Nordisk’s shares gain after the drugmaker withdraws from a bidding war over the obesity drug maker Metsera. Caitlin McCabe hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices